MARKET

IART

IART

Integra Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

69.63
+1.35
+1.98%
After Hours: 69.63 0 0.00% 16:21 09/17 EDT
OPEN
68.27
PREV CLOSE
68.28
HIGH
69.78
LOW
67.96
VOLUME
752.31K
TURNOVER
--
52 WEEK HIGH
77.40
52 WEEK LOW
42.12
MARKET CAP
5.89B
P/E (TTM)
28.82
1D
5D
1M
3M
1Y
5Y
BTIG Downgrades Integra Lifesciences to Neutral
BTIG analyst Ryan Zimmerman downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Neutral.
Benzinga · 2d ago
BTIG Downgrades Integra LifeSciences Holdings to Neutral from Buy
MT Newswires · 2d ago
Advanced Wound Care Market: Business overview, Upcoming Trends and Top Company Analysis Forecast to 2028
Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2028"which delivers detailed overview of the global advanced wound care market in terms of market segmentation by product, by wound type, by end user and by region.
AmericaNewsHour · 3d ago
Notable Integra Lifesciences Insider Trades $11.46 Million In Company Stock
Peter Arduini, President And Ceo at Integra Lifesciences (NASDAQ:IART), made a large buy and sell of company shares on September 3, according to a new SEC filing.
Benzinga · 09/08 21:57
Insider Sell: Integra Lifesciences Holdings
MT Newswires · 09/07 17:00
Integra Lifesciences Holdings Corp (IART) President & CEO Peter J Arduini Sold $9 million ...
GuruFocus News · 09/07 09:26
Integra LifeSciences Announces Participation in Upcoming Investor Conferences
PRINCETON, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: On September 9, 2021,...
GlobeNewswire · 09/02 20:01
Is It Too Late To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Integra LifeSciences Holdings Corporation ( NASDAQ:IART ), might not be a large cap stock, but it saw a double-digit...
Simply Wall St. · 09/02 14:07
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IART. Analyze the recent business situations of Integra Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IART stock price target is 77.70 with a high estimate of 88.00 and a low estimate of 55.00.
EPS
Institutional Holdings
Institutions: 409
Institutional Holdings: 78.68M
% Owned: 93.02%
Shares Outstanding: 84.58M
TypeInstitutionsShares
Increased
93
1.87M
New
36
686.48K
Decreased
77
1.17M
Sold Out
28
391.01K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/Independent Director
Stuart Essig
Chief Executive Officer/President/Director
Peter Arduini
Chief Financial Officer/Executive Vice President
Carrie Anderson
Chief Operating Officer/Executive Vice President
Glenn Coleman
Chief Human Resource Officer/Executive Vice President
Lisa Evoli
Executive Vice President/Secretary
Eric Schwartz
Executive Vice President
Robert Davis
Executive Vice President
Michael Mcbreen
Senior Vice President/Chief Accounting Officer
Jeffrey Mosebrook
Lead Director/Independent Director
Barbara Hill
Independent Director
Rhonda Ballintyn
Independent Director
Keith Bradley
Independent Director
Shaundra Clay
Independent Director
Donald Morel
Independent Director
Raymond Murphy
Independent Director
Christian Schade
No Data
  • All
  • Financials
  • Insiders
More
About IART
Integra LifeSciences Holdings Corporation provides regenerative technologies and neurosurgical solutions. The Company offers a portfolio of brands including AmnioExcel, Bactiseal, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. The Company offers solutions in orthopedics, neurosurgery, and reconstructive and general surgery. The Company operates through two segments: Codman Specialty Surgical segment, and Orthopedics and Tissue Technologies segment. The Codman Specialty Surgical segment includes the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care. The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.

Webull offers kinds of Integra Lifesciences Holdings Corp stock information, including NASDAQ:IART real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IART stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IART stock methods without spending real money on the virtual paper trading platform.